Mode of action of kujimycins, neutral macrolide antibiotics.
J. Sawada,S. Namiki,M. Onodera,S. Omura,I. Tanaka
DOI: https://doi.org/10.7164/ANTIBIOTICS.27.639
1974-08-01
Abstract:JIRO SAWADA, SHINJURO NAMIKI, MERI ONODERA, SADAFUMI OMURA and ICHIRO TANAKA Research Division, Taisho Pharmaceutical Co., Ltd., No. 34-1, Takata 3-chome, Toshima-ku, Tokyo, Japan (Received for publication February 18, 1974) Many investigations have been reported1) on the mode of action of basic macrolide antibiotics, which inhibit the peptide elongation step and do not inhibit the initiation, codon recognition and termination steps in protein synthesis of bacterial cells. Furthermore, a 16-membered basic macrolide, spiramycin (SPM)2) inhibits the binding of aminoacyltRNA to ribosomes but a 14-membered one, erythromycin (EM)3), does not. MAO4) and VAZQUEZS5) reported that a 14membered neutral macrolide, lankamycin and a 16-membered one, chalcomycin (CHL), inhibited the amino acids incorporation in Escherichia coli cell-free system and thereby these antibiotics are also assumed to inhibit the peptide elongation step. But lankamycin and CHL have never been compared on each step in protein synthesis such as the binding of aminoacyl-tRNA to ribosomes. In the present study, we have examined the mode of action of kujimycin A(KJM-A) and kujimycin B(KJM-B; syn. lankamycine6)), compared their inhibition type and looked for some The reaction mixture contained, in a final volume of 0.25 ml: 2311 moles of tris-HCl (pH 7.4), 47 It moles of NH4Cl, 3.711 moles of MgCl2. 250 m1e moles of GTP, 2.9 u moles of DTT, 11s mole of 12 C-phenylalanine, 5011g of poly U, 0.103 mg protein of dialyzed 100S fraction, 0.123 mg protein of ribosomes and 14C-phenylalanyl-tRNA (20,896 c.p.m.) with or without antibiotics. Incubation time was 5 minutes at 37°C.